CStone Reports 2024 Interim Results and Recent Corporate Updates ...Middle East

News by : (PR Newswire) -
Total revenue of RMB 254.2 million for 2024 H1; achieving first-time profitability with cash reserve at RMB 814 million as of June 30, 2024. NDA approval of sugemalimab (PD-L1) for Stage IV NSCLC in EU, marking the first successful international approval of a China domestic anti-PD-L1 mAb....

Hence then, the article about cstone reports 2024 interim results and recent corporate updates was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CStone Reports 2024 Interim Results and Recent Corporate Updates )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار